Skip to main content
NCBI home page
British Heart Journal logoLink to British Heart Journal
. 1991 Nov;66(5):359–363. doi: 10.1136/hrt.66.5.359

Estimating the size of myocardial infarction by magnetic resonance imaging.

L W Turnbull 1, J P Ridgway 1, J J Nicoll 1, D Bell 1, J J Best 1, A L Muir 1
PMCID: PMC1024774  PMID: 1836135

Abstract

OBJECTIVE--To develop a method to measure myocardial infarct size by magnetic resonance imaging and to compare the results with pyrophosphate scanning by single photon emission computed tomography. DESIGN--All patients underwent magnetic resonance imaging and pyrophosphate scanning 5-7 days after the onset of symptoms. Both measurements of infarct size were compared with the release of creatine kinase MB and with ventricular performance estimated by radionuclide ventriculography. PATIENTS--19 patients (age 40-68 years) who had sustained their first uncomplicated myocardial infarction and who had not been treated with thrombolytic therapy. RESULTS--The site of infarction was clearly shown by both imaging techniques and was identical in each patient. The volume of infarcted tissue measured by magnetic resonance imaging agreed well with the infarct size measured by single photon emission tomography (mean difference 2.7 cm3). Correlations of both imaging techniques with the release of creatine kinase MB were best when total release rather than peak release was used. Both imaging techniques correlated closely with the subsequent ventricular performance. CONCLUSIONS--Magnetic resonance imaging after acute infarction allows measurement of infarct size and this may prove useful in assessing new treatments designed to salvage myocardium.

Full text

PDF
359

Images in this article

360Image
on p.360
361Image
on p.361

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Alonso D. R., Scheidt S., Post M., Killip T. Pathophysiology of cardiogenic shock. Quantification of myocardial necrosis, clinical, pathologic and electrocardiographic correlations. Circulation. 1973 Sep;48(3):588–596. doi: 10.1161/01.cir.48.3.588. [DOI] [PubMed] [Google Scholar]
  2. Been M., Smith M. A., Ridgeway J. P., Brydon J. W., Douglas R. H., Kean D. M., Best J. J., Muir A. L. Characterisation of acute myocardial infarction by gated magnetic resonance imaging. Lancet. 1985 Aug 17;2(8451):348–350. doi: 10.1016/s0140-6736(85)92494-8. [DOI] [PubMed] [Google Scholar]
  3. Been M., Smith M. A., Ridgway J. P., Douglas R. H., de Bono D. P., Best J. J., Muir A. L. Serial changes in the T1 magnetic relaxation parameter after myocardial infarction in man. Br Heart J. 1988 Jan;59(1):1–8. doi: 10.1136/hrt.59.1.1. [DOI] [PMC free article] [PubMed] [Google Scholar]
  4. Bland J. M., Altman D. G. Statistical methods for assessing agreement between two methods of clinical measurement. Lancet. 1986 Feb 8;1(8476):307–310. [PubMed] [Google Scholar]
  5. Brown J. J., Higgins C. B. Myocardial paramagnetic contrast agents for MR imaging. AJR Am J Roentgenol. 1988 Nov;151(5):865–871. doi: 10.2214/ajr.151.5.865. [DOI] [PubMed] [Google Scholar]
  6. Buja L. M., Parkey R. W., Stokely E. M., Bonte F. J., Willerson J. T. Pathophysiology of technetium-99m stannous pyrophosphate and thallium-201 scintigraphy of acute anterior myocardial infarcts in dogs. J Clin Invest. 1976 Jun;57(6):1508–1522. doi: 10.1172/JCI108421. [DOI] [PMC free article] [PubMed] [Google Scholar]
  7. Caputo G. R., Sechtem U., Tscholakoff D., Higgins C. B. Measurement of myocardial infarct size at early and late time intervals using MR imaging: an experimental study in dogs. AJR Am J Roentgenol. 1987 Aug;149(2):237–243. doi: 10.2214/ajr.149.2.237. [DOI] [PubMed] [Google Scholar]
  8. Corbett J. R., Lewis M., Willerson J. T., Nicod P. H., Huxley R. L., Simon T., Rude R. E., Henderson E., Parkey R., Rellas J. S. 99mTc-pyrophosphate imaging in patients with acute myocardial infarction: comparison of planar imaging with single-photon tomography with and without blood pool overlay. Circulation. 1984 Jun;69(6):1120–1128. doi: 10.1161/01.cir.69.6.1120. [DOI] [PubMed] [Google Scholar]
  9. Jansen D. E., Corbett J. R., Wolfe C. L., Lewis S. E., Gabliani G., Filipchuk N., Redish G., Parkey R. W., Buja L. M., Jaffe A. S. Quantification of myocardial infarction: a comparison of single photon-emission computed tomography with pyrophosphate to serial plasma MB-creatine kinase measurements. Circulation. 1985 Aug;72(2):327–333. doi: 10.1161/01.cir.72.2.327. [DOI] [PubMed] [Google Scholar]
  10. Kluge W. F. Prognostic value of serum creatine phosphokinase levels in myocardial infarction. Northwest Med. 1969 Sep;68(9):847–853. [PubMed] [Google Scholar]
  11. Lewis S. E., Devous M. D., Sr, Corbett J. R., Izquierdo C., Nicod P., Wolfe C. L., Parkey R. W., Buja L. M., Willerson J. T. Measurement of infarct size in acute canine myocardial infarction by single-photon emission computed tomography with technetium-99m pyrophosphate. Am J Cardiol. 1984 Jul 1;54(1):193–199. doi: 10.1016/0002-9149(84)90328-x. [DOI] [PubMed] [Google Scholar]
  12. Muir A. L., Hannan W. J., Sapru R. P., Boardman A. K., Wraith P. K., Brash H. M. The effects of isoprenaline, atropine and dobutamine on ventricular volume curves obtained by radionuclide ventriculography. Clin Sci (Lond) 1980 May;58(5):357–364. doi: 10.1042/cs0580357. [DOI] [PubMed] [Google Scholar]
  13. Muller J. E., Maroko P. R., Braunwald E. Evaluation of precordial electrocardiographic mapping as a means of assessing changes in myocardial ischemic injury. Circulation. 1975 Jul;52(1):16–27. doi: 10.1161/01.cir.52.1.16. [DOI] [PubMed] [Google Scholar]
  14. Murray R. G., Peshock R. M., Parkey R. W., Bonte F. J., Willerson J. T., Blomqvist C. G. ST isopotential precordial surface maps in patients with acute myocardial infarction. J Electrocardiol. 1979 Jan;12(1):55–64. doi: 10.1016/s0022-0736(79)80045-x. [DOI] [PubMed] [Google Scholar]
  15. Page D. L., Caulfield J. B., Kastor J. A., DeSanctis R. W., Sanders C. A. Myocardial changes associated with cardiogenic shock. N Engl J Med. 1971 Jul 15;285(3):133–137. doi: 10.1056/NEJM197107152850301. [DOI] [PubMed] [Google Scholar]
  16. Rokey R., Verani M. S., Bolli R., Kuo L. C., Ford J. J., Wendt R. E., Schneiders N. J., Bryan R. N., Roberts R. Myocardial infarct size quantification by MR imaging early after coronary artery occlusion in dogs. Radiology. 1986 Mar;158(3):771–774. doi: 10.1148/radiology.158.3.3945752. [DOI] [PubMed] [Google Scholar]
  17. Shell W. E., Kjekshus J. K., Sobel B. E. Quantitative assessment of the extent of myocardial infarction in the conscious dog by means of analysis of serial changes in serum creatine phosphokinase activity. J Clin Invest. 1971 Dec;50(12):2614–2625. doi: 10.1172/JCI106762. [DOI] [PMC free article] [PubMed] [Google Scholar]
  18. Tscholakoff D., Higgins C. B., Sechtem U., Caputo G., Derugin N. MRI of reperfused myocardial infarct in dogs. AJR Am J Roentgenol. 1986 May;146(5):925–930. doi: 10.2214/ajr.146.5.925. [DOI] [PubMed] [Google Scholar]
  19. Uniform requirements for manuscripts submitted to biomedical journals: International Committee of Medical Journal Editors. Br Heart J. 1983 Jan;49(1):1–7. [PMC free article] [PubMed] [Google Scholar]
  20. White H. D., Norris R. M., Brown M. A., Takayama M., Maslowski A., Bass N. M., Ormiston J. A., Whitlock T. Effect of intravenous streptokinase on left ventricular function and early survival after acute myocardial infarction. N Engl J Med. 1987 Oct 1;317(14):850–855. doi: 10.1056/NEJM198710013171402. [DOI] [PubMed] [Google Scholar]

Articles from British Heart Journal are provided here courtesy of BMJ Publishing Group

RESOURCES